October 4, 2020, 03.05 PM

WASHINGTON, KOMPAS.com – After announcing his positive coronavirus diagnosis, Trump’s Covid-19 treatment turns to Regeneron’s antibody drug that remains unapproved as of yet.

The experimental drug given to President Donald Trump has been called one of the most promising approaches to preventing serious illness from a Covid-19 infection.

The company behind Regeneron’s antibody drug, Regeneron Pharmaceuticals Inc., said that it agreed to supply a single dose as part of Trump’s Covid-19 treatment.

Read also: Donald Trump Tests Positive for Coronavirus, Begins Quarantine

The company administered the drug through an IV and at the request of Trump’s physician under “compassionate use” provisions.

The latter refers to a situation when an experimental medicine is provided on a case-by-case emergency basis, while studies of it continue.

The new drug is in late-stage testing and its safety and effectiveness are not yet known. No treatment has yet proved able to prevent serious illness after a coronavirus infection.

Read also: Germany Approves Third Trial of IDT Biologika Covid-19 Vaccine

Trump was given the experimental drug at the White House on Friday before he was taken to Walter Reed National Military Medical Center, where he’ll be monitored, officials said. So far, Trump has had only mild symptoms, including fatigue.

Several physicians who treat Covid-19, including Dr. David Boulware at the University of Minnesota, had speculated that doctors might use the antibody drug, given that this approach has worked against other diseases in the past.

Page:


Latest Video

Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Report
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

News
September 30, 2022, 07.14 PM

Indonesia Approves First Homegrown Covid-19 Vaccine

News
September 29, 2022, 09.40 PM

Indonesia, Singapore to Intensify Marine Patrols

News
September 26, 2022, 06.21 PM

Six People Killed in Philippine Typhoon

Business
September 20, 2022, 10.22 PM

EU Hopes for Trade Pact with Indonesia within Two Years

Close Ads